Pharmacological Modulation of Cocaine Effects - 1

NCT00000201 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

Cocaine-Related Disorders

Interventions

DRUG: Selegiline

Sponsor

National Institute on Drug Abuse (NIDA)

Collaborators

[object Object]